Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole.
A total of 100 and 97% of Haemophilus influenzae type b strains from major infections were susceptible, respectively, to levels of rifampin and sulfisoxazole attainable in saliva. It is theoretically feasible to eliminate Haemophilus influenzae from the nasopharynx with these drugs.
D006193:Haemophilus influenzae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D012293:Rifampin / Q000494:pharmacology*; D013444:Sulfisoxazole / Q000494:pharmacology*
D013444:Sulfisoxazole; D012293:Rifampin